DOCSLIB.ORG

Oncogenic Role of SFRP2 in P53-Mutant Osteosarcoma Development Via Autocrine and Paracrine Mechanism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oncogenic Role of SFRP2 in P53-Mutant Osteosarcoma Development Via Autocrine and Paracrine Mechanism Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism Huensuk Kima,b,c, Seungyeul Yood,e, Ruoji Zhouf,g,AnXuf, Jeffrey M. Bernitza,b,c, Ye Yuana,b,c, Andreia M. Gomesa,b,h,i, Michael G. Daniela,b,c, Jie Sua,b,c,j, Elizabeth G. Demiccok,l, Jun Zhud,e, Kateri A. Moorea,b,c, Dung-Fang Leea,b,f,g,m,n,1,2, Ihor R. Lemischkaa,b,c,o,1,3, and Christoph Schaniela,b,c,o,p,1,2 aDepartment of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; bThe Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029; cThe Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; dDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; eIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; fDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030; gThe University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030; hCentre for Neuroscience and Cell Biology, University of Coimbra, 3030-789 Coimbra, Portugal; iInstitute for Interdisciplinary Research, University of Coimbra, 3030-789 Coimbra, Portugal; jCancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065; kDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; lDepartment of Pathology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; mCenter for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030; nCenter for Precision Health, School of Biomedical Informatics and School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030; oDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and pMount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029 Edited by Randall T. Moon, University of Washington, Seattle, WA, and approved October 4, 2018 (received for review August 26, 2018) Osteosarcoma (OS), the most common primary bone tumor, is highly showed that SFRP2 hypermethylation and its decreased ex- metastatic with high chemotherapeutic resistance and poor survival pression are associated with prostate, liver, colorectal, and gas- rates. Using induced pluripotent stem cells (iPSCs) generated from Li– tric cancer (22–27). Originally, SFRP2 was reported as a secreted Fraumeni syndrome (LFS) patients, we investigate an oncogenic role antiapoptosis-related protein (28, 29). Ectopic expression of of secreted frizzled-related protein 2 (SFRP2) in p53 mutation- SFRP2 promotes cell growth and has antiapoptotic properties in associated OS development. Interestingly, we find that high renal and breast cancer (30–32). The role of SFRP2 appears to SFRP2 expression in OS patient samples correlates with poor survival. be cancer-type specific and remains controversial. Thus, in- MEDICAL SCIENCES Systems-level analyses identified that expression of SFRP2 increases vestigation and understanding of the role of SFRP2 in different during LFS OS development and can induce angiogenesis. Ectopic types of cancer, including OS, is warranted. SFRP2 overexpression in normal osteoblast precursors is sufficient Using induced pluripotent stem cells (iPSCs) derived from to suppress normal osteoblast differentiation and to promote OS LFS patients, we previously recapitulated the pathophysiological phenotypes through induction of oncogenic molecules such as FOXM1 and CYR61 in a β-catenin–independent manner. Conversely, Significance inhibition of SFRP2, FOXM1, or CYR61 represses the tumorigenic po- tential. In summary, these findings demonstrate the oncogenic role Li–Fraumeni syndrome is a rare disorder caused by germline of SFRP2 in the development of p53 mutation-associated OS and that TP53 mutations, predisposing patients to early-onset cancers, inhibition of SFRP2 is a potential therapeutic strategy. including osteosarcoma (OS). Here we demonstrate that strong expression of SFRP2, a reported WNT antagonist, in OS patient SFRP2 | p53 | osteosarcoma | autocrine | paracrine samples correlates with poor survival and that SFRP2 over- expression suppresses normal osteoblast differentiation, pro- steosarcoma (OS) is the most common primary bone tumor. motes OS features, and facilitates angiogenesis via autocrine OIt accounts for about 60% of all primary bone tumors and and paracrine mechanisms in an induced pluripotent stem cell about 2% of all childhood cancers (1, 2). Despite significant disease model. We show that these SFRP2-mediated phenotypes advances in OS treatment modalities, the 5-y overall survival rate are canonical WNT/β-catenin independent and are mediated has remained stable over the last 20 y at 60–70% for patients through induction of oncogenes such as FOXM1 and CYR61. We with primary OS and less than 30% for patients with metastasis further demonstrate that inhibition of SFRP2, FOXM1, or CYR61 (3, 4). This stagnation of clinical outcomes underlines the urgent represses tumorigenesis. Our data suggest that inhibition of necessity for novel model systems to study the mechanism of OS SFRP2 should be explored clinically as a strategy for treatment in a patient-specific context and to identify molecular targets for patients with p53 mutation-associated OS. the development of new therapeutic strategies. The tumor suppressor p53 regulates cell cycle, apoptosis, se- Author contributions: H.K., D.-F.L., I.R.L., and C.S. designed research; H.K., R.Z., A.X., nescence, metabolism, and cell differentiation (5–7). Therefore, it J.M.B., Y.Y., A.M.G., M.G.D., J.S., E.G.D., and K.A.M. performed research; K.A.M. contrib- uted new reagents/analytic tools; H.K., S.Y., E.G.D., J.Z., and D.-F.L. analyzed data; and is not surprising that aberrant p53 expression contributes signifi- H.K., S.Y., D.-F.L., I.R.L., and C.S. wrote the paper. cantly to cancer development (8, 9). Half of all human sporadic The authors declare no conflict of interest. bone tumors have genetic lesions in TP53 (10, 11). Patients with Li–Fraumeni syndrome (LFS), which is caused by mutations in This article is a PNAS Direct Submission. TP53, show a 500-fold higher incidence of OS relative to the Published under the PNAS license. general population (12–14). Manipulation of p53 function con- Data deposition: The RNA-sequencing data have been deposited in the Gene Expression firmed its significance in OS development (15, 16) and identified Omnibus databank (accession nos. GSE102729 and GSE102732). mesenchymal stem cells (MSCs) and preosteoblasts (pre-OBs) as 1D.-F.L., I.R.L., and C.S. contributed equally to this work. the cellular origin of OS (17, 18). Osteoblast (OB)-restricted de- 2To whom correspondence may be addressed. Email: [email protected] or letion of p53/Mdm2 or p53/Rb resulted in OS development at a [email protected]. high penetrance of about 60% and 100%, respectively (19, 20). 3Deceased December 7, 2017. The first secreted frizzled-related protein (SFRP) was identi- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. fied as a WNT antagonist (21). As a known WNT antagonist, 1073/pnas.1814044115/-/DCSupplemental. SFRP2 is considered a tumor suppressor. Indeed, several reports www.pnas.org/cgi/doi/10.1073/pnas.1814044115 PNAS Latest Articles | 1of10 Downloaded by guest on September 30, 2021 features of LFS-mediated OS development (33, 34). Taking ad- vantage of this platform, we observed increased expression of SFRP2 during LFS iPSC-derived OB differentiation. As a result of these findings and because the exact function of SFPR2 in OS is not clear, we investigated its role in LFS p53 mutation-mediated abnormal OB differentiation, tumorigenesis, and OS develop- ment. Here, we report that SFRP2 overexpression (SFRP2OE) induces OS phenotypes, increases FOXM1 expression, and pro- motes angiogenesis and endothelial expression of the matricellular protein CYR61. Conversely, targeting SFRP2OE in LFS and OS has therapeutic promise for OS subtypes with p53 mutations. Results SFRP2OE Is Associated with p53 Mutation-Mediated Human OS Development. To discover potential therapeutic targets for LFS- mediated OS, we compared the genome-wide transcripts of the LFS dataset (GSE58123) composed of MSCs differentiated to OBs in vitro from two LFS (P53p.G245D) patient iPSC lines, LFS1-A and LFS2-B, and one control iPSC line, WT-1 (SI Appendix,Table S1) (33), with an OS tumor-initiating cell dataset (GSE33458) (Fig. 1A) (35). We first identified differentially expressed genes (DEGs) between LFS and WT cells in the GSE58123 dataset. Because the dataset includes only one sample for each differentiation time point (D0, D7, D14, and D17), we performed a paired t test be- tween each of the two LFS patient iPSC-derived samples with WT cells and identified DEGs common to both LFS samples with respect to WT cells (fold change >2, paired t test P < 0.01) (Dataset S1). This method enabled extraction of consistently up- or down-regulated DEGs (Fig. 1A). We identified SFRP2, which showed the greatest fold change (>30), as an overexpressed gene Fig. 1. SFRP2OE in LFS (G245D)-mediated OS. (A, Left) Global transcriptome with potential implication in OS development. Quantitative PCR analysis of LFS P53p.G245D- and WT iPSCs-derived MSCs differentiated to OBs. (Right) DEGs between LFS and WT cells were sorted by paired t test (P < 0.01) and Western blot analyses confirmed that SFRP2 expression is > significantly overexpressed in OBs derived from different LFS iPSC with a fold change 2. SFRP2 is an overexpressed gene that is also enriched in B the signature gene list of an OS gene set (GSE33458).
Load more

Recommended publications
  • Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis
    Hindawi Disease Markers Volume 2019, Article ID 3521746, 10 pages https://doi.org/10.1155/2019/3521746 Research Article Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis Wei Liu,1 Jishi Ye,2 and Hong Yan 1 1Department of Anesthesiology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China 2Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060 Hubei, China Correspondence should be addressed to Hong Yan; [email protected] Received 2 November 2018; Accepted 31 December 2018; Published 10 February 2019 Academic Editor: Hubertus Himmerich Copyright © 2019 Wei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. The neurobiological mechanisms underlying the chemotherapy-induced neuropathic pain are only partially understood. Among them, microglia activation was identified as the key component of neuropathic pain. The aim of this study was to identify differentially expressed genes (DEGs) and pathways associated with vincristine-induced neuropathic pain by using bioinformatics analysis and observe the effects of oxycodone on these DEG expressions in a vincristine-induced microglia activation model. Methods. Based on microarray profile GSE53897, we identified DEGs between vincristine-induced neuropathic pain rats and the control group. Using the ToppGene database, the prioritization DEGs were screened and performed by gene ontology (GO) and signaling pathway enrichment. A protein-protein interaction (PPI) network was used to explore the relationship among DEGs.
    [Show full text]
  • Three Dact Gene Family Members Are Expressed During Embryonic Development
    Three Dact Gene Family Members are Expressed During Embryonic Development and in the Adult Brains of Mice Daniel A Fisher, Saul Kivimäe, Jun Hoshino, Rowena Suriben, Pierre -Marie Martin, Nichol Baxter, Benjamin NR Cheyette Department of Psychiatry & Gra duate Programs in Developmental Biology and Neuroscience, University of California, San Francisco, 94143-2611 Correspondence: Benjamin NR Cheyette [email protected] 415.476.7826 Running Title: Mouse Dact Gene Family Expression Key Words: mouse, Dpr, Frodo, Thyex, Dact, Wnt, Dvl, expression, embryo, brain Supported by: NIH: MH01750 K08; NARSAD Young Investigator Award; NAAR award #551. Abstract Members of the Dact protein family were initially identified through binding to Dishevelled (Dvl), a cytoplasmic protein central to Wnt signaling. During mouse development, Dact1 is detected in the presomitic mesoderm and somites during segmentation, in the limb bud mesenchyme and other mesoderm-derived tissues, and in the central nervous system (CNS). Dact2 expression is most prominent during organogenesis of the thymus, kidneys, and salivary glands, with much lower levels in the somites and in the developing CNS. Dact3, not previously described in any organism, is expressed in the ventral region of maturing somites, limb bud and branchial arch mesenchyme, and in the embryonic CNS; of the three paralogs it is the most highly expressed in the adult cerebral cortex. These data are consistent with studies in other vertebrates showing that Dact paralogs have distinct signaling and developmental roles, and suggest they may differentially contribute to postnatal brain physiology. Introduction Signaling downstream of secreted Wnt ligands is a conserved process in multicellular animals that plays important roles during development and, when misregulated, contributes to cancer and other diseases (Polakis, 2000; Moon et al., 2002).
    [Show full text]
  • Multivariate Analysis Reveals Differentially Expressed Genes
    www.nature.com/scientificreports OPEN Multivariate analysis reveals diferentially expressed genes among distinct subtypes of difuse astrocytic gliomas: diagnostic implications Nerea González‑García1,2, Ana Belén Nieto‑Librero1,2, Ana Luisa Vital3, Herminio José Tao4, María González‑Tablas2,5,6, Álvaro Otero2, Purifcación Galindo‑Villardón1,2, Alberto Orfao2,5,6 & María Dolores Tabernero2,5,6,7* Diagnosis and classifcation of gliomas mostly relies on histopathology and a few genetic markers. Here we interrogated microarray gene expression profles (GEP) of 268 difuse astrocytic gliomas—33 difuse astrocytomas (DA), 52 anaplastic astrocytomas (AA) and 183 primary glioblastoma (GBM)—based on multivariate analysis, to identify discriminatory GEP that might support precise histopathological tumor stratifcation, particularly among inconclusive cases with II–III grade diagnosed, which have diferent prognosis and treatment strategies. Microarrays based GEP was analyzed on 155 difuse astrocytic gliomas (discovery cohort) and validated in another 113 tumors (validation set) via sequential univariate analysis (pairwise comparison) for discriminatory gene selection, followed by nonnegative matrix factorization and canonical biplot for identifcation of discriminatory GEP among the distinct histological tumor subtypes. GEP data analysis identifed a set of 27 genes capable of diferentiating among distinct subtypes of gliomas that might support current histological classifcation. DA + AA showed similar molecular profles with only a few discriminatory genes
    [Show full text]
  • Transcriptomic and Epigenomic Characterization of the Developing Bat Wing
    ARTICLES OPEN Transcriptomic and epigenomic characterization of the developing bat wing Walter L Eckalbar1,2,9, Stephen A Schlebusch3,9, Mandy K Mason3, Zoe Gill3, Ash V Parker3, Betty M Booker1,2, Sierra Nishizaki1,2, Christiane Muswamba-Nday3, Elizabeth Terhune4,5, Kimberly A Nevonen4, Nadja Makki1,2, Tara Friedrich2,6, Julia E VanderMeer1,2, Katherine S Pollard2,6,7, Lucia Carbone4,8, Jeff D Wall2,7, Nicola Illing3 & Nadav Ahituv1,2 Bats are the only mammals capable of powered flight, but little is known about the genetic determinants that shape their wings. Here we generated a genome for Miniopterus natalensis and performed RNA-seq and ChIP-seq (H3K27ac and H3K27me3) analyses on its developing forelimb and hindlimb autopods at sequential embryonic stages to decipher the molecular events that underlie bat wing development. Over 7,000 genes and several long noncoding RNAs, including Tbx5-as1 and Hottip, were differentially expressed between forelimb and hindlimb, and across different stages. ChIP-seq analysis identified thousands of regions that are differentially modified in forelimb and hindlimb. Comparative genomics found 2,796 bat-accelerated regions within H3K27ac peaks, several of which cluster near limb-associated genes. Pathway analyses highlighted multiple ribosomal proteins and known limb patterning signaling pathways as differentially regulated and implicated increased forelimb mesenchymal condensation in differential growth. In combination, our work outlines multiple genetic components that likely contribute to bat wing formation, providing insights into this morphological innovation. The order Chiroptera, commonly known as bats, is the only group of To characterize the genetic differences that underlie divergence in mammals to have evolved the capability of flight.
    [Show full text]
  • Comprehensive Analysis of SFRP Family Members Prognostic Value and Immune Infiltration in Gastric Cancer
    life Article Comprehensive Analysis of SFRP Family Members Prognostic Value and Immune Infiltration in Gastric Cancer Dehua Liu 1 , Chenyu Sun 2 , Nahyun Kim 2 , Chandur Bhan 2, John Pocholo Whitaker Tuason 2, Yue Chen 3, Shaodi Ma 4, Yuting Huang 5 , Ce Cheng 6,7, Qin Zhou 8 and Kaiguang Zhang 1,* 1 The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China; [email protected] 2 Internal Medicine, AMITA Health Saint Joseph Hospital Chicago, Chicago, IL 60657, USA; [email protected] (C.S.); [email protected] (N.K.); [email protected] (C.B.); [email protected] (J.P.W.T.) 3 Department of Clinical Medicine, School of the First Clinical Medicine, Anhui Medical University, Hefei 230032, China; [email protected] 4 Department of Epidemiology and Health Statistics, School of Public Health Anhui Medical University, Hefei 230032, China; [email protected] 5 University of Maryland Medical Center Midtown Campus, Baltimore, MD 21201, USA; [email protected] 6 The University of Arizona College of Medicine, Banner University Medical Center at South Campus, Tucson, AZ 85724, USA; [email protected] 7 Banner-University Medical Center South, Tucson, AZ 85713, USA 8 Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA; [email protected] * Correspondence: [email protected]; Tel.: +86-138-5517-0097 Citation: Liu, D.; Sun, C.; Kim, N.; Abstract: Gastric cancer (GC) is the fifth most common cancer globally. Secreted frizzled-related Bhan, C.; Tuason, J.P.W.; Chen, Y.; Ma, proteins (SFRP) are important elements associated with the Wnt signaling pathway, and its dysregu- S.; Huang, Y.; Cheng, C.; Zhou, Q.; lated expression is found in multiple cancers.
    [Show full text]
  • Genomic and Transcriptome Analysis Revealing an Oncogenic Functional Module in Meningiomas
    Neurosurg Focus 35 (6):E3, 2013 ©AANS, 2013 Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas XIAO CHANG, PH.D.,1 LINGLING SHI, PH.D.,2 FAN GAO, PH.D.,1 JONATHAN RUssIN, M.D.,3 LIYUN ZENG, PH.D.,1 SHUHAN HE, B.S.,3 THOMAS C. CHEN, M.D.,3 STEVEN L. GIANNOTTA, M.D.,3 DANIEL J. WEISENBERGER, PH.D.,4 GAbrIEL ZADA, M.D.,3 KAI WANG, PH.D.,1,5,6 AND WIllIAM J. MAck, M.D.1,3 1Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; 2GHM Institute of CNS Regeneration, Jinan University, Guangzhou, China; 3Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; 4USC Epigenome Center, Keck School of Medicine, University of Southern California, Los Angeles, California; 5Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, California; and 6Division of Bioinformatics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California Object. Meningiomas are among the most common primary adult brain tumors. Although typically benign, roughly 2%–5% display malignant pathological features. The key molecular pathways involved in malignant trans- formation remain to be determined. Methods. Illumina expression microarrays were used to assess gene expression levels, and Illumina single- nucleotide polymorphism arrays were used to identify copy number variants in benign, atypical, and malignant me- ningiomas (19 tumors, including 4 malignant ones). The authors also reanalyzed 2 expression data sets generated on Affymetrix microarrays (n = 68, including 6 malignant ones; n = 56, including 3 malignant ones).
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]
  • Role of Extracellular Vesicles in Human Papillomavirus-Induced
    Chapter Role of Extracellular Vesicles in Human Papillomavirus-Induced Tumorigenesis Giorgio Mangino, Maria Vincenza Chiantore, Marco Iuliano, Lorena Capriotti, Luisa Accardi, Paola Di Bonito, Gianna Fiorucci and Giovanna Romeo Abstract Emerging evidence demonstrates a role of extracellular vesicles (EVs) in a vari- ety of fundamental physiological and pathological processes ranging from antigen presentation to T cell to neurodegenerative diseases. In several types of malignan- cies, a variety of EVs can be isolated from bodily fluids of cancer patients, and it has been reported that the number of circulating EVs seems to be higher than in healthy subjects. This increase correlates with poor prognosis. Data obtained from different groups clearly point out a role of EVs in the transfer of bioactive molecules such as microRNAs and viral oncoproteins in human papillomavirus-induced malignan- cies of genital and oral tracts. This study summarizes these data in the context of relevant literature considering the EVs as carriers of oncogenic signatures in human cancer as well as their therapeutic potential in HPV-related tumors. Keywords: extracellular vesicles, exosomes, microvesicles, human papillomavirus, tumorigenesis 1. Introduction The extracellular vesicles (EVs) are nano- to micro-sized, cell-derived structures delimited by a double-layer lipid membrane. Even if the first reports describing the existence of “particles” derived from platelets with procoagulant effects and the presence in serum of the so-called platelets dust date back to 1946 and 1967, respectively [1], exosomes have been considered for a long time just as cell “rubbish” materials. Spotlight on EV functions have been turned on in the early 1980s when two different groups convincingly demonstrated the role of EVs in the transfer and recycling of transferrin receptor in reticulocytes [2, 3].
    [Show full text]
  • Secreted Frizzled-Related Protein 2 (Sfrp2) Redirects Non-Canonical Wnt Signaling from Fz7 to Ror2 During Vertebrate Gastrulation
    Secreted frizzled-related protein 2 (sFRP2) redirects non-canonical Wnt signaling from Fz7 to Ror2 during vertebrate gastrulation DISSERTATION submitted to the Combined Faculties of the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences Eva-Maria Brinkmann 2015 Dissertation submitted to the Combined Faculties of the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences presented by Dipl.-Ing./ M.Sc Eva-Maria Brinkmann born in: Steinfurt, Germany Oral examination: ………………… Secreted frizzled-related protein 2 (sFRP2) redirects non-canonical Wnt signaling from Fz7 to Ror2 during vertebrate gastrulation Referees: Dr. Suat Özbek Prof. Dr. Thomas Holstein This thesis is dedicated to Herbert Steinbeisser. Acknowledgements The past 4 years at the University of Heidelberg were very formative and full of precious experiences. I would not have made it successfully without the contribution of the following people. My deepest appreciation goes to my supervisor Herbert Steinbeisser who gave me the opportunity to work in his research group. Herbert, thank you for your excellent guidance, encouragement and scientific feedback. You were a great mentor for me. I am deeply grateful to Suat Özbek and Lilian Kaufmann, who supervised and supported me at the end of my thesis. Thank you for your guidance, constant interest and valuable suggestions. Without you, I wouldn´t have been able to bring my thesis to a good end. Special thanks to Christof Niehrs and to the members of the Niehrs group for supportive discussions and progress reports.
    [Show full text]
  • Myofibroblast Transcriptome Indicates SFRP2+ Fibroblast Progenitors in Systemic
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.30.442148; this version posted April 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Myofibroblast transcriptome indicates SFRP2+ fibroblast progenitors in systemic sclerosis skin Tracy Tabib1, Mengqi Huang1, Nina Morse1, Anna Papazoglou1, Rithika Behera1, Minxue Jia2, Melissa Bulik1, Daisy E. Monier1, Panayiotis V. Benos2, Wei Chen3, Robyn Domsic1, Robert Lafyatis1 1Division of Rheumatology and Clinical Immunology, Department of Medicine; 2Depatment of Computational and Systems Biology; 3Division of Pulmonary Medicine, Allergy and Immunology, Department of Pediatrics; School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA Corresponding Author: Robert Lafyatis, MD, Address: BST S720, 200 Lothrop St, Pittsburgh, PA 15260 Telephone: 412 383-9045 E-mail: [email protected] Disclosures Dr. Lafyatis reports grants from Bristol Meyer Squib, Corbus, Formation, Moderna, Regeneron, Pfizer, and Kiniksa, outside the submitted work; and served as a consultant with Bristol Meyers Squibb, Formation, Sanofi, Boehringer-Ingelheim, Merck, and Genentech/Roche. 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.30.442148; this version posted April 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Skin and lung fibrosis in systemic sclerosis (SSc) is driven by myofibroblasts, alpha- smooth muscle actin expressing cells that arise from a variety of cell types in murine fibrosis models. Utilizing single cell RNA-sequencing to examine the transcriptome changes, we show that SSc dermal myofibroblasts arise from an SFRP2/DPP4-expressing progenitor fibroblast population that globally upregulates expression of transcriptome markers, such as PRSS23 and THBS1.
    [Show full text]
  • Aberrantly Methylated-Differentially Genes and Pathways Among Iranian
    Ghorbani et al. Cancer Cell Int (2021) 21:346 https://doi.org/10.1186/s12935-021-02053-0 Cancer Cell International PRIMARY RESEARCH Open Access Aberrantly methylated-diferentially genes and pathways among Iranian patients with colorectal cancer Mahla Ghorbani1,2†, Marjan Azghandi2,3† and Mohammad Amin Kerachian2,4,5* Abstract Background: Methylation plays an important role in colorectal cancer (CRC) pathogenesis. The goal of this study was to identify aberrantly diferentially methylated genes (DMGs) and pathways through bioinformatics analysis among Iranian CRC patients using Methylation Next Generation Sequencing. Methods: This study has integrated results of SureSelectXT Methyl-Seq Target with the potential key candidate genes and pathways in CRC . Six CRC and six samples of normal colon were integrated and deeply analyzed. In addition to this gene methylation profling, several other gene methylation profling datasets were obtained from Gene Expres- sion Omnibus (GEO) and TCGA datasets. DMGs were sorted and candidate genes and enrichment pathways were analyzed. DMGs-associated protein–protein interaction network (PPI) was constructed based on the STRING online database. Results: Totally, 320 genes were detected as common genes between our patients and selected GEO and TCGA datasets from the Agilent SureSelect analysis with selecting criteria of p-value < 0.05 and FC 1.5. DMGs were identi- fed from hyper-DMGs PPI network complex and 10 KEGG pathways were identifed. The most≥ important modules were extracted from MCODE, as most of the corresponding genes were involved in cellular process and protein binding. Conclusions: Hub genes including WNT2, SFRP2, ZNF726 and BMP2 were suggested as potentially diagnostic and therapeutic targets for CRC.
    [Show full text]
  • DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers
    cells Review DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers Chameera Ekanayake Weeramange 1,2,3, Kai Dun Tang 1,2 , Sarju Vasani 4,5, Julian Langton-Lockton 6, Liz Kenny 5,7,8 and Chamindie Punyadeera 1,2,* 1 Saliva & Liquid Biopsy Translational Research Team, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology (QUT), Queensland 4059, Australia; [email protected] (C.E.W.); [email protected] (K.D.T.) 2 Translational Research Institute, Queensland University of Technology (QUT), Queensland 4102, Australia 3 Department of Medical Laboratory Sciences, Faculty of Health Sciences, The Open University of Sri Lanka, Nugegoda 10250, Sri Lanka 4 Department of Otolaryngology, Royal Brisbane and Women’s Hospital, Queensland 4029, Australia; [email protected] 5 School of Medicine, The University of Queensland, Queensland 4006, Australia; [email protected] 6 Metro-North Sexual Health and HIV Service, Queensland 4000, Australia; [email protected] 7 Department of Cancer Care Services, Royal Brisbane and Women’s Hospital, Queensland 4029, Australia 8 Central Integrated Regional Cancer Service, Queensland Health, Queensland 4001, Australia * Correspondence: [email protected]; Tel.: +61-7-3138-0830 Received: 8 May 2020; Accepted: 28 May 2020; Published: 31 May 2020 Abstract: Disruption of DNA methylation patterns is one of the hallmarks of cancer. Similar to other cancer types, human papillomavirus (HPV)-driven head and neck cancer (HNC) also reveals alterations in its methylation profile. The intrinsic ability of HPV oncoproteins E6 and E7 to interfere with DNA methyltransferase activity contributes to these methylation changes.
    [Show full text]